Literature DB >> 7666061

The pathology of peroxisomal disorders with pathogenetic considerations.

J M Powers1.   

Abstract

Peroxisomal disorders are rare systemic maladies in which specific major organ systems are typically involved: most importantly the central nervous system (CNS), but also the peripheral nervous system, eyes, liver, adrenal, kidney and skeleton. Zellweger syndrome (ZS) is the most severe of the generalized types and exhibits major neocortical migration defects, less severe and non-inflammatory white matter lesions, and dysmorphic features. In adrenoleukodystrophy (ALD) the major lesion again is in the CNS, but consists of extensive dysmyelination/inflammatory demyelination without neuronal migration defects or dysmorphism. In adrenomyeloneuropathy long tract degeneration of spinal cord, peripheral neuropathy, and variable CNS dysmyelinative to inflammatory demyelinative lesions are the dominant nervous system lesions. Saturated very long chain fatty acids, either free in the cytoplasm of affected endocrine cells or as components of membrane lipids (e.g. gangliosides, glycerophospholipids, and proteolipid protein) in axons or myelin, may be central to the pathogenesis of these neuronal migration defects, dysmyelination/inflammatory demyelination and spinal tract degeneration. Cytokines, particularly tumor necrosis factor-alpha, and delayed cellular hypersensitivity appear to be major secondary pathogenic factors in ALD.

Entities:  

Mesh:

Year:  1995        PMID: 7666061

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  14 in total

Review 1.  Infantile hypertrophic pyloric stenosis--genetics and syndromes.

Authors:  Babette Peeters; Marc A Benninga; Raoul C M Hennekam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-10       Impact factor: 46.802

Review 2.  Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Authors:  Inderjit Singh; Aurora Pujol
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

3.  Peroxisomal multifunctional protein-2 deficiency causes motor deficits and glial lesions in the adult central nervous system.

Authors:  Steven Huyghe; Henning Schmalbruch; Leen Hulshagen; Paul Van Veldhoven; Myriam Baes; Dieter Hartmann
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

4.  T2 relaxation measurements in X-linked adrenoleukodystrophy performed using dual-echo fast fluid-attenuated inversion recovery MR imaging.

Authors:  E R Melhem; T F Gotwald; R Itoh; S J Zinreich; H W Moser
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

Review 5.  Urodynamic abnormalities in two brothers with adrenomyeloneuropathy.

Authors:  M M Walther; G B Cutler
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 6.  The myelin mutants as models to study myelin repair in the leukodystrophies.

Authors:  Ian D Duncan; Yoichi Kondo; Su-Chun Zhang
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

7.  Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse).

Authors:  E Baumgart; I Vanhorebeek; M Grabenbauer; M Borgers; P E Declercq; H D Fahimi; M Baes
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 8.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

9.  Plasmalogen deficiency in cerebral adrenoleukodystrophy and its modulation by lovastatin.

Authors:  Mushfiquddin Khan; Jaspreet Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2008-06-07       Impact factor: 5.372

10.  Neuronal migration depends on intact peroxisomal function in brain and in extraneuronal tissues.

Authors:  Anneleen Janssen; Pierre Gressens; Markus Grabenbauer; Eveline Baumgart; Arno Schad; Ilse Vanhorebeek; Annelies Brouwers; Peter E Declercq; Dariush Fahimi; Philippe Evrard; Luc Schoonjans; Désiré Collen; Peter Carmeliet; Guy Mannaerts; Paul Van Veldhoven; Myriam Baes
Journal:  J Neurosci       Date:  2003-10-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.